Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
03/2002
03/12/2002US6355454 Generation of lysine, threonine, isoleucine, valine, proline, tryptophan or homoserine in preferential microorganism; obtain microorganism, ferment microorganism, accumulate amino acids, recover amino acids
03/12/2002US6355447 Screening for modulators of target protein; obtain sample, incubate with target proteins, monitor activity of sample, adjustment in target protein activity indicates presence of modulator
03/12/2002US6355443 4-(4-hydroxystyryl) pyridine-containing substrates for an analyte dependent enzyme activation system
03/12/2002US6355255 Streptococcal C5a peptidase vaccine
03/12/2002US6355243 Method of thrombolysis by local delivery of active plasmin
03/12/2002US6355228 Oral care product comprising a mutan binding domain
03/12/2002CA2048567C Liquid lipase from animal origin and method of preparation
03/12/2002CA1341346C Antisense gene systems of pollination control for hybrid seed production
03/07/2002WO2002018654A1 Induction of ldl receptor expression by extracellular-signal regulated kinase, erk-1/2
03/07/2002WO2002018623A2 Methods and reagents for protease inhibition
03/07/2002WO2002018618A2 PROCESS FOR THE PREPARATION OF A β-LACTAM NUCLEUS AND THE APPLICATION THEREOF
03/07/2002WO2002018617A2 Carotenoid production by recombinant, c1-metabolizing methanothropic bacteria
03/07/2002WO2002018614A1 METHOD OF ELEVATING YIELD OF OLIGOSACCHARIDES CONTAINING α-GALACTOSYL AND ANTI-CANDIDA COMPOSITIONS
03/07/2002WO2002018613A1 NUCLEOTIDE SEQUENCES WHICH CODE FOR THE metY GENE
03/07/2002WO2002018612A1 Method for an enzymatic reaction of compounds having at least one nitrile function and/or at least one amide function
03/07/2002WO2002018611A2 Method for the improved production and isolation of trans-dihydroxycyclohexadiene carboxylic acids and/or derivatives thereof and a genetically modified organism suitable for the above
03/07/2002WO2002018607A2 Transgenic plants containing molecular decoys that alter protein content therein
03/07/2002WO2002018606A1 Novel starches produced by the expression of heterologous granule bound starch synthase genes
03/07/2002WO2002018604A2 Methods and compositions for determining isomerase enzymatic activity
03/07/2002WO2002018603A1 Isomaltulose synthase
03/07/2002WO2002018602A1 Novel polypeptide
03/07/2002WO2002018591A1 Method of performing reverse transcription reaction using reverse transcriptase encoded by non-ltr retrotransposable element
03/07/2002WO2002018588A1 Method for screening highly active proteases and inhibitors
03/07/2002WO2002018587A1 Process for producing biopterins
03/07/2002WO2002018585A2 Packaging of positive-strand rna virus replicon particles
03/07/2002WO2002018582A2 62112, a novel human dehydrogenase and uses thereof
03/07/2002WO2002018574A2 Human interleukin-four induced protein
03/07/2002WO2002018570A1 Yeast transformant producing recombinant human parathyroid hormone and method for producing the hormone
03/07/2002WO2002018567A2 Regulation of human aminotransferase-like enzyme
03/07/2002WO2002018566A2 Regulation of human l-asparaginase-like enzyme
03/07/2002WO2002018565A2 Regulation of human protein phosphatase iic-like enzyme
03/07/2002WO2002018562A1 Airway-specific trypsin-like enzymes and method of using the same
03/07/2002WO2002018561A2 Modified fungal xylanases
03/07/2002WO2002018560A2 Butinol i esterase
03/07/2002WO2002018559A2 50566, human glyoxalase ii related factor and uses thereof
03/07/2002WO2002018558A2 27439, a human hydroxylase and uses therefor
03/07/2002WO2002018557A2 Human kinases
03/07/2002WO2002018556A2 8797, a human galactosyltransferase and uses thereof
03/07/2002WO2002018555A2 Human kinase proteins and polynucleotides encoding the same
03/07/2002WO2002018554A2 Isolated human drug-metabolizing proteins, nucleic acid moleculesand uses thereof
03/07/2002WO2002018553A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/07/2002WO2002018552A2 Regulation of human aminotransferase-like enzyme
03/07/2002WO2002018551A2 Method for producing ligninolytic enzymes using wood-inhabiting fungi from the order agaricales
03/07/2002WO2002018548A2 Tyrosine hydroxylase 5' control elements and uses thereof
03/07/2002WO2002018547A1 Methods for reducing polyamine biosynthesis and the plants and seeds produced thereby
03/07/2002WO2002018541A2 A neural specific cystosolic sulfotransferase for drug screening
03/07/2002WO2002018447A1 Fusion protein containing additional cationic amino acids and improvement of bio-operation by using same
03/07/2002WO2002018430A2 Nucleotide sequences which code for the metr and metz genes
03/07/2002WO2002018427A2 Nucleotide sequences which code for the cita gene
03/07/2002WO2002018378A1 Pyrrolidine derivatives and their use as chymase inhibitor
03/07/2002WO2002018369A2 Peptidomimetic protease inhibitors
03/07/2002WO2002018341A2 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors
03/07/2002WO2002017856A2 Compositions and methods relating to hypertension
03/07/2002WO2001090305A8 LACTOBACILLUSβ -GLUCURONIDASE AND DNA ENCODING THE SAME
03/07/2002WO2001080810A9 Chondroitin synthase gene and methods of making and using same
03/07/2002WO2001075040A3 A novel peptide human pterin molybdenum oxidation-reduction enzyme 12 and the polynucleotide coding this novel peptide
03/07/2002WO2001075001A3 A novel polypeptide, cyclic adenosine 9-dependant human protein kinase and the polynucleotide encoding the polypeptide
03/07/2002WO2001074855A3 Compositions and methods for dendritic cell-based immunotherapy
03/07/2002WO2001066710A3 Human ribonuclease
03/07/2002WO2001064887A3 32705, 23224, 27423, 32700, 32712, novel human g-proteins
03/07/2002WO2001064838A3 Thermophilic dna polymerases from thermoactinomyces vulgaris
03/07/2002WO2001062948A3 Method and catalyst system for stereoselectively inverting a chiral center of a chemical compound
03/07/2002WO2001060414A3 Genetic modification of the lung as a portal for gene delivery
03/07/2002WO2001059130A3 Proteins producing an altered immunogenic response and methods of making and using the same
03/07/2002WO2001059090A3 CDK4 IS A TARGET OF c-MYC
03/07/2002WO2001059078A3 Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
03/07/2002WO2001059075A8 Improved sialylation of glycoproteins
03/07/2002WO2001057220A3 Human enzymes and polynucleotides encoding the same
03/07/2002WO2001055335A3 Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides
03/07/2002WO2001055174A3 Universal procedure for refolding recombinant proteins
03/07/2002WO2001053501A3 Glutathione-s-transferase nucleic acids and polypeptides and methods of use thereof
03/07/2002WO2001053493A3 Human kinase protein and polynucleotides encoding the same
03/07/2002WO2001053468A3 Lipid metabolism enzymes and polynucleotides encoding them
03/07/2002WO2001051624A3 Carboxypeptidase b free of animal products and contaminating enyzme activity
03/07/2002WO2001042280A3 Short peptides from the b4 and b5 regions of protein kinases which selectively modulate protein activity
03/07/2002WO2001037194A3 Crystallizable compositions comprising a caspase-7
03/07/2002WO2001032888A3 Human transferase molecules
03/07/2002WO2001023539A3 Genes encoding sterol delta-15 reductase in plants
03/07/2002WO2001021772A3 Methods and microorganisms for production of panto-compounds
03/07/2002WO2001019994A3 PLANT APOPTOSIS INDUCING FACTORS (AIFs)
03/07/2002WO2001007575A3 Subtilisin protease variants having amino acid deletions and substitutions in defined epitope regions
03/07/2002US20020029394 Homologs of starch synthase DU1
03/07/2002US20020028954 Useful as biodegradable surfactants and in enzymatic processes using a chitinase (N-acetylglucosaminidase)
03/07/2002US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis
03/07/2002US20020028772 Modulation of metabolism
03/07/2002US20020028496 Genetic engineering; infecting insect cell with baculovirus; culturing
03/07/2002US20020028495 Deoxyribonuclease II beta proteins and cDNAs
03/07/2002US20020028490 Gene enhancement
03/07/2002US20020028481 Expression using fused genes providing for protein product
03/07/2002US20020028267 Activity-stable and low-dust; used, for example, in the production of baked goods and farinaceous products, in starch processing, or in brewing
03/07/2002US20020028212 Recombinant viruses coding for a glutamate decarboxylase (gad) activity
03/07/2002US20020028205 May be comprised of a heavily glycosylated mucin part, which mediates binding to selectins, such as PSGL-1; absorber to prevent a hyperacute rejection of a xenotransplant
03/07/2002US20020028199 Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein C (APC)
03/07/2002US20020028198 DNA coding for the protein; useful for a prophylactic or therapeutic agent for hypoglycemia.
03/07/2002CA2697205A1 Peptidomimetic protease inhibitors
03/07/2002CA2424052A1 Packaging of positive-strand rna virus replicon particles
03/07/2002CA2421088A1 Novel polypeptide
03/07/2002CA2420877A1 Isomaltulose synthase
03/07/2002CA2420832A1 Methods and reagents for protease inhibition
03/07/2002CA2420724A1 Transgenic plants containing molecular decoys that alter protein content therein
1 ... 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 ... 1416